Skip to content
Brand AI

Enterprise Therapeutics Ltd.

Recent events

Recent events tied to this brand in public sources.

Back to profile1 entries

  1. 2020

    Roche acquires Enterprise Therapeutics' TMEM16A potentiator portfolio

    Roche acquired Enterprise Therapeutics' TMEM16A potentiator portfolio, which will be developed by Genentech, a member of the Roche Group. Enterprise shareholders are eligible for additional contingent payments tied to predetermined milestones.

    Source